Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism
Abstract Background Gastric cancer (GC) is a commonly occurring human malignancy. The 5-fluorouracil (5-Fu) is a first-line anti-gastric cancer agent. However, a large number of GC patients developed 5-Fu resistance. Currently, the roles and molecular mechanisms of the lncRNA-SNHG16-modulated 5-Fu r...
Main Authors: | Yan Ding, Sujie Gao, Jiabin Zheng, Xuebo Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Cancer & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40170-022-00293-w |
Similar Items
-
LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement
by: Cong Zhang, et al.
Published: (2023-09-01) -
LncRNA SNHG3, a potential oncogene in human cancers
by: Bin Xu, et al.
Published: (2020-11-01) -
LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
by: Yiran Liang, et al.
Published: (2020-05-01) -
Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p
by: Xi Yang, et al.
Published: (2020-02-01) -
LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141
by: Ke Liu, et al.
Published: (2017-07-01)